STOCK TITAN

[Form 4] Marsh & McLennan Companies, Inc. Insider Trading Activity

Filing Impact
(High)
Filing Sentiment
(Very Negative)
Form Type
4
Rhea-AI Filing Summary

Marsh & McLennan Companies insider transaction by John Q. Doyle. The filing reports that on 09/02/2025 Mr. Doyle exercised 21,079 stock options with an exercise price of $63.09 and immediately sold 21,079 shares at $205.65 per share. The transactions were executed pursuant to a previously adopted Rule 10b5-1 trading plan. After these transactions Mr. Doyle beneficially owned 87,681.0205 shares of MMC directly. The options exercised were originally granted on May 1, 2016 and vested in four equal annual installments beginning May 1, 2017, with full vesting by 2020.

Operazione interna in Marsh & McLennan Companies da parte di John Q. Doyle. Il documento segnala che il 02/09/2025 il Sig. Doyle ha esercitato 21.079 opzioni su azioni con prezzo di esercizio di $63,09 e ha immediatamente venduto 21.079 azioni a $205,65 ciascuna. Le operazioni sono state eseguite nell'ambito di un piano di negoziazione Rule 10b5-1 precedentemente adottato. Dopo queste operazioni il Sig. Doyle deteneva direttamente in modo beneficiario 87.681,0205 azioni di MMC. Le opzioni esercitate erano state originate il 1 maggio 2016 e sono maturate in quattro rate annuali uguali a partire dal 1 maggio 2017, con piena maturazione entro il 2020.

Operación de un insider de Marsh & McLennan Companies por John Q. Doyle. El informe indica que el 02/09/2025 el Sr. Doyle ejerció 21.079 opciones sobre acciones con un precio de ejercicio de $63,09 y vendió de inmediato 21.079 acciones a $205,65 cada una. Las transacciones se realizaron conforme a un plan de negociación Rule 10b5-1 adoptado previamente. Tras estas operaciones, el Sr. Doyle poseía beneficiariamente de forma directa 87.681,0205 acciones de MMC. Las opciones ejercidas se otorgaron originalmente el 1 de mayo de 2016 y se consolidaron en cuatro cuotas anuales iguales a partir del 1 de mayo de 2017, con consolidación total en 2020.

Marsh & McLennan Companies의 내부자 거래: John Q. Doyle. 제출서류에 따르면 2025-09-02에 Doyle 씨는 행사가격 $63.09의 스톡옵션 21,079주를 행사했고, 즉시 주당 $205.6521,079주를 매도했습니다. 이 거래들은 사전에 채택된 Rule 10b5-1 거래계획에 따라 실행되었습니다. 이들 거래 후 Doyle 씨는 MMC를 직접적으로 87,681.0205주 보유하고 있었습니다. 행사된 옵션은 원래 2016년 5월 1일에 부여되었고, 2017년 5월 1일부터 연단위로 4등분해 권리가 발생하여 2020년에 완전히 베스팅되었습니다.

Opération d'initié chez Marsh & McLennan Companies par John Q. Doyle. Le dossier indique que le 02/09/2025 M. Doyle a exercé 21 079 options d'achat d'actions au prix d'exercice de $63,09 et a immédiatement vendu 21 079 actions à $205,65 chacune. Les transactions ont été exécutées dans le cadre d'un plan de négociation Rule 10b5-1 précédemment adopté. Après ces opérations, M. Doyle détenait directement à titre bénéficiaire 87 681,0205 actions de MMC. Les options exercées avaient été initialement attribuées le 1er mai 2016 et se sont acquises en quatre versements annuels égaux à partir du 1er mai 2017, avec une acquisition totale en 2020.

Insider-Transaktion bei Marsh & McLennan Companies durch John Q. Doyle. Die Einreichung berichtet, dass Herr Doyle am 02.09.2025 21.079 Aktienoptionen mit einem Ausübungspreis von $63,09 ausgeübt und sofort 21.079 Aktien zu je $205,65 verkauft hat. Die Transaktionen wurden im Rahmen eines zuvor angenommenen Rule 10b5-1-Handelsplans ausgeführt. Nach diesen Transaktionen hielt Herr Doyle direkt wirtschaftlich 87.681,0205 Aktien von MMC. Die ausgeübten Optionen wurden ursprünglich am 1. Mai 2016 gewährt und sind in vier gleichen jährlichen Tranchen ab dem 1. Mai 2017 vestingwirksam geworden, mit vollständiger Vesting im Jahr 2020.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Officer exercised vested 2016 options and sold the resulting shares under a pre-existing 10b5-1 plan; impact appears routine.

The report documents a simultaneous exercise-and-sale of 21,079 shares by the President & CEO, executed under an established Rule 10b5-1 plan on 09/02/2025. The exercise price was $63.09 with a sale price of $205.65 per share, and the reporting person retains 87,681.0205 shares post-transaction. From a disclosure and compliance viewpoint, reliance on a 10b5-1 plan and the fact that the options were long-vested (granted 2016, vested by 2020) indicate a routine liquidity event rather than a special issuance or amendment.

TL;DR: Transaction follows governance best practices by using a documented 10b5-1 plan; no new benefit plan grants disclosed.

The Form 4 shows the CEO transacted under a declared trading plan, which provides an affirmative defense under Rule 10b5-1. The filing discloses the original grant date and vesting schedule for the options (May 1, 2016, vested in four installments through 2020), supporting clarity on option maturity. The disclosure is complete for the reported activities and includes an attorney-in-fact signature confirming timely filing.

Operazione interna in Marsh & McLennan Companies da parte di John Q. Doyle. Il documento segnala che il 02/09/2025 il Sig. Doyle ha esercitato 21.079 opzioni su azioni con prezzo di esercizio di $63,09 e ha immediatamente venduto 21.079 azioni a $205,65 ciascuna. Le operazioni sono state eseguite nell'ambito di un piano di negoziazione Rule 10b5-1 precedentemente adottato. Dopo queste operazioni il Sig. Doyle deteneva direttamente in modo beneficiario 87.681,0205 azioni di MMC. Le opzioni esercitate erano state originate il 1 maggio 2016 e sono maturate in quattro rate annuali uguali a partire dal 1 maggio 2017, con piena maturazione entro il 2020.

Operación de un insider de Marsh & McLennan Companies por John Q. Doyle. El informe indica que el 02/09/2025 el Sr. Doyle ejerció 21.079 opciones sobre acciones con un precio de ejercicio de $63,09 y vendió de inmediato 21.079 acciones a $205,65 cada una. Las transacciones se realizaron conforme a un plan de negociación Rule 10b5-1 adoptado previamente. Tras estas operaciones, el Sr. Doyle poseía beneficiariamente de forma directa 87.681,0205 acciones de MMC. Las opciones ejercidas se otorgaron originalmente el 1 de mayo de 2016 y se consolidaron en cuatro cuotas anuales iguales a partir del 1 de mayo de 2017, con consolidación total en 2020.

Marsh & McLennan Companies의 내부자 거래: John Q. Doyle. 제출서류에 따르면 2025-09-02에 Doyle 씨는 행사가격 $63.09의 스톡옵션 21,079주를 행사했고, 즉시 주당 $205.6521,079주를 매도했습니다. 이 거래들은 사전에 채택된 Rule 10b5-1 거래계획에 따라 실행되었습니다. 이들 거래 후 Doyle 씨는 MMC를 직접적으로 87,681.0205주 보유하고 있었습니다. 행사된 옵션은 원래 2016년 5월 1일에 부여되었고, 2017년 5월 1일부터 연단위로 4등분해 권리가 발생하여 2020년에 완전히 베스팅되었습니다.

Opération d'initié chez Marsh & McLennan Companies par John Q. Doyle. Le dossier indique que le 02/09/2025 M. Doyle a exercé 21 079 options d'achat d'actions au prix d'exercice de $63,09 et a immédiatement vendu 21 079 actions à $205,65 chacune. Les transactions ont été exécutées dans le cadre d'un plan de négociation Rule 10b5-1 précédemment adopté. Après ces opérations, M. Doyle détenait directement à titre bénéficiaire 87 681,0205 actions de MMC. Les options exercées avaient été initialement attribuées le 1er mai 2016 et se sont acquises en quatre versements annuels égaux à partir du 1er mai 2017, avec une acquisition totale en 2020.

Insider-Transaktion bei Marsh & McLennan Companies durch John Q. Doyle. Die Einreichung berichtet, dass Herr Doyle am 02.09.2025 21.079 Aktienoptionen mit einem Ausübungspreis von $63,09 ausgeübt und sofort 21.079 Aktien zu je $205,65 verkauft hat. Die Transaktionen wurden im Rahmen eines zuvor angenommenen Rule 10b5-1-Handelsplans ausgeführt. Nach diesen Transaktionen hielt Herr Doyle direkt wirtschaftlich 87.681,0205 Aktien von MMC. Die ausgeübten Optionen wurden ursprünglich am 1. Mai 2016 gewährt und sind in vier gleichen jährlichen Tranchen ab dem 1. Mai 2017 vestingwirksam geworden, mit vollständiger Vesting im Jahr 2020.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Doyle John Q

(Last) (First) (Middle)
1166 AVENUE OF THE AMERICAS

(Street)
NEW YORK NY 10036

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
MARSH & MCLENNAN COMPANIES, INC. [ MMC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
President and CEO
3. Date of Earliest Transaction (Month/Day/Year)
09/02/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/02/2025 M(1) 21,079 A $63.09 108,760.0205 D
Common Stock 09/02/2025 S(1) 21,079 D $205.65 87,681.0205 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Options (Right to Buy) $63.09 09/02/2025 M(1) 21,079 (2) 04/30/2026 Common Stock 21,079 $0 21,079 D
Explanation of Responses:
1. This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
2. These options were granted on May 1, 2016 and vested in four equal annual installments on May 1st of 2017, 2018, 2019 and 2020.
/s/ Tessa Patti, Attorney-in-fact 09/03/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did John Q. Doyle report on the Form 4 for MMC?

The Form 4 reports that John Q. Doyle exercised 21,079 stock options at $63.09 and sold 21,079 shares at $205.65 on 09/02/2025 under a Rule 10b5-1 plan.

How many MMC shares does John Q. Doyle beneficially own after the transaction?

After the reported transactions Mr. Doyle beneficially owns 87,681.0205 shares of MMC.

Were the exercised options vested and when were they granted?

Yes. The options were granted on May 1, 2016 and vested in four equal annual installments on May 1 of 2017, 2018, 2019 and 2020.

Was the sale part of a pre-arranged trading plan?

Yes. The filing states the transactions were effected pursuant to a previously adopted Rule 10b5-1 trading plan.

Who signed the Form 4 filing?

The Form 4 was signed by Tessa Patti, Attorney-in-fact on behalf of the reporting person on 09/03/2025.
Marsh & Mclennan

NYSE:MMC

MMC Rankings

MMC Latest News

MMC Latest SEC Filings

MMC Stock Data

101.33B
491.22M
0.07%
92.5%
1.22%
Insurance Brokers
Insurance Agents, Brokers & Service
Link
United States
NEW YORK